Inflammation in Vascular Disease

NCT03732612 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2025-05-06

No results posted yet for this study

Summary

Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease.

Conditions

Sponsors & Collaborators

  • Göteborg University

    lead OTHER

Principal Investigators

  • Jan Boren, MD, PhD · The University of Gothenburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-02
Primary Completion
2026-02-01
Completion
2027-02-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03732612 on ClinicalTrials.gov